Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243
- PMID: 41077698
- DOI: 10.1111/bjh.70203
Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243
Keywords: MDS; TAK‐243; VEXAS syndrome; pevonedistat.
References
REFERENCES
-
- Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult‐onset autoinflammatory disease. N Engl J Med. 2020;383:2628–2638. https://doi.org/10.1056/NEJMoa2026834
-
- Wu Z, Gao S, Gao Q, Patel BA, Groarke EM, Feng X, et al. Early activation of inflammatory pathways in UBA1‐mutated hematopoietic stem and progenitor cells in VEXAS. Cell Rep Med. 2023;4:101160. https://doi.org/10.1016/j.xcrm.2023.101160
-
- Lobato‐Gil S, Heidelberger JB, Maghames C, Bailly A, Brunello L, Rodriguez MS, et al. Proteome‐wide identification of NEDD8 modification sites reveals distinct proteomes for canonical and atypical NEDDylation. Cell Rep. 2021;34:108635. https://doi.org/10.1016/j.celrep.2020.108635
-
- Georgin‐Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2022;186:564–574. https://doi.org/10.1111/bjd.20805
-
- Patel N, Dulau‐Florea A, Calvo KR. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome. Semin Hematol. 2021;58:204–211. https://doi.org/10.1053/j.seminhematol.2021.10.007
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
